Lorediplon
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Systematic (IUPAC) name | |
---|---|
N-{2-fluoro-5-[3-(thiophen-2-ylcarbonyl)pyrazolo[1,5-a]pyrimidin-7-yl]phenyl}-N-methylacetamide
|
|
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 917393-39-6 Y |
ATC code | None |
PubChem | CID 12004146 |
ChemSpider | 10176613 Y |
Chemical data | |
Formula | C20H15FN4O2S |
Molar mass | 394.422 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Lorediplon (INN) is a nonbenzodiazepine of the pyrazolopyrimidine family that is being pursued as a treatment for insomnia but has not completed development.[1]
References[edit]
- ^ World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN): Proposed INN: List 105" (PDF). WHO Drug Information. 25 (2): 179.
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids |
|
Imidazoles | |
Kava constituents | |
Monoureides | |
Neuroactive steroids |
|
Nonbenzodiazepines |
|
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|
See also: GABAergics
|
This sedative-related article is a stub. You can help Wikipedia by expanding it. |